Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of
BRCA-mutation
DNA methylation
cancer susceptibility
deltaNp73
tissue-specificity
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Aug 2020
21 Aug 2020
Historique:
received:
29
07
2020
revised:
13
08
2020
accepted:
18
08
2020
entrez:
23
8
2020
pubmed:
23
8
2020
medline:
23
8
2020
Statut:
epublish
Résumé
The function of BRCA1/2 proteins is essential for maintaining genomic integrity in all cell types. However, why women who carry deleterious germline mutations in
Identifiants
pubmed: 32825620
pii: cancers12092367
doi: 10.3390/cancers12092367
pmc: PMC7564633
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Israel Cancer Association
ID : ICA #20160039
Organisme : Cancer Biology Research Center, Tel Aviv University
ID : CBRC, TAU #0601243842
Références
Cancer Cell. 2002 Mar;1(2):129-32
pubmed: 12086871
Lancet. 2005 Nov 19;366(9499):1784-93
pubmed: 16298215
Mol Cell. 2009 Aug 28;35(4):534-41
pubmed: 19716796
Lancet. 2018 Sep 1;392(10149):777-786
pubmed: 30100054
Cell. 2017 Jun 1;169(6):1105-1118.e15
pubmed: 28575672
Cell Cycle. 2016;15(5):621-7
pubmed: 26822887
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Annu Rev Pathol. 2009;4:461-87
pubmed: 18954285
Genes Dev. 2010 Mar 15;24(6):549-60
pubmed: 20194434
Science. 2015 Jan 2;347(6217):78-81
pubmed: 25554788
Elife. 2017 Nov 06;6:
pubmed: 29106372
Nat Commun. 2015 Jun 24;6:7505
pubmed: 26106036
Cancer Res. 2002 Jul 1;62(13):3598-602
pubmed: 12097259
J Vis Exp. 2013 Jan 03;(71):
pubmed: 23328888
Nat Commun. 2014 Nov 17;5:5496
pubmed: 25400221
Nucleic Acids Res. 2006 Feb 06;34(3):840-52
pubmed: 16464822
Science. 2014 Mar 28;343(6178):1470-5
pubmed: 24675954
Nat Genet. 2009 Feb;41(2):178-186
pubmed: 19151715
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17773-8
pubmed: 21987798
Cancer Res. 2014 May 15;74(10):2773-2784
pubmed: 24638981
Br J Cancer. 2007 Jan 15;96(1):11-5
pubmed: 17213823
Mol Cell Biol. 2000 Oct;20(20):7450-9
pubmed: 11003642
Mol Cell Biol. 2003 Aug;23(16):5540-55
pubmed: 12897129
PLoS One. 2014 Mar 20;9(3):e91805
pubmed: 24651077
Nat Rev Cancer. 2007 Mar;7(3):165-8
pubmed: 17332760
J Exp Med. 2002 Sep 16;196(6):765-80
pubmed: 12235210
Cell Death Differ. 2001 Dec;8(12):1213-23
pubmed: 11753569
Trends Genet. 2003 Jun;19(6):312-5
pubmed: 12801723
Genes Dev. 2010 Mar 15;24(6):517-20
pubmed: 20231313
Mol Cancer. 2009 Aug 11;8:61
pubmed: 19671150
Genes Dev. 2008 Oct 1;22(19):2677-91
pubmed: 18805989
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):797-802
pubmed: 19139399
J Biol Chem. 2000 Oct 13;275(41):31869-75
pubmed: 10884389
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2230-2234
pubmed: 28193856
Oncogene. 2015 Aug 13;34(33):4287-99
pubmed: 25381823
Science. 1997 Nov 7;278(5340):1043-50
pubmed: 9353177
Cancers (Basel). 2018 Dec 14;10(12):
pubmed: 30558184
J Clin Pathol. 2018 Jan;71(1):52-58
pubmed: 28743687
Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10642-E10651
pubmed: 30352856
Nat Protoc. 2009;4(4):495-505
pubmed: 19300443
Cell. 2010 Apr 16;141(2):243-54
pubmed: 20362325
Nat Protoc. 2006;1(6):2643-9
pubmed: 17406520